BMEA

Biomea Fusion, Inc.

5.33 USD
-0.22 (-3.96%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Biomea Fusion, Inc. stock is down -54.25% since 30 days ago. The next earnings date is Jul 29, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 6 PUTs, 4 CALLs. 75% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
10 Jun 14:43 18 Oct, 2024 12.50 PUT 190 131
10 Jun 19:04 18 Oct, 2024 5.00 CALL 500 1440
11 Jun 19:05 17 Jan, 2025 10.00 PUT 459 1058
11 Jun 19:05 17 Jan, 2025 10.00 PUT 100 1058
11 Jun 19:05 17 Jan, 2025 10.00 PUT 583 1058
12 Jun 15:13 18 Oct, 2024 5.00 CALL 999 3087
12 Jun 15:29 18 Oct, 2024 5.00 CALL 350 3087
12 Jun 15:30 18 Oct, 2024 5.00 CALL 1500 3087
14 Jun 15:22 17 Jan, 2025 5.00 PUT 200 120
21 Jun 14:12 18 Oct, 2024 12.50 PUT 190 321

About Biomea Fusion, Inc.

Biomea Fusion, Inc. focuses on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers and metabolic diseases. BMF-219, an orally bioavailable, potent, and selective irreversible inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers.

  • HC Wainwright & Co.
    Tue Jun 25, 06:56
    buy
    confirm
  • Truist Securities
    Tue Jun 11, 08:07
    hold
    downgrade
  • Citigroup
    Fri Jun 7, 14:25
    buy
    confirm
  • HC Wainwright & Co.
    Fri Jun 7, 12:55
    buy
    confirm
  • Piper Sandler
    Fri Jun 7, 10:04
    buy
    confirm
  • Barclays
    Fri Jun 7, 09:35
    hold
    downgrade
  • ScotiaBank
    Fri Jun 7, 09:01
    buy
    confirm
  • Oppenheimer
    Thu May 30, 10:23
    buy
    confirm